Inventor
STANEK JAROSLAV
CH36 patents
⚠️ This page may combine multiple inventors who share the name “STANEK JAROSLAV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CIBA GEIGY CORP
32 patentsUS4971986ANov 20, 1990
Arylhydrazones useful as SAMDC inhibitors
CIBA GEIGY CORP54 citations96
US5627215AMay 6, 1997
Unsaturate amino compounds for use as anticancer and antiprotozoic agent
CIBA GEIGY CORP24 citations92
US5064832ANov 12, 1991
Biaryl compounds
CIBA GEIGY CORP40 citations92
US4968804ANov 6, 1990
Bipyridine compounds
CIBA GEIGY CORP41 citations92
US4439425AMar 27, 1984
Peptide derivatives
CIBA GEIGY CORP50 citations92
US4409209AOct 11, 1983
Novel phosphorylmuramyl peptides and processes for the manufacture thereof
CIBA GEIGY CORP29 citations92
US4406890ASep 27, 1983
Novel lipophilic muramyl peptides and processes for their manufacture
CIBA GEIGY CORP40 citations92
US4323560AApr 6, 1982
Novel phosphorylmuramyl peptides and processes for the manufacture thereof
CIBA GEIGY CORP33 citations92
US4446128AMay 1, 1984
Antigen derivatives and processes for their preparation
CIBA GEIGY CORP29 citations91
US4414204ANov 8, 1983
Antibiotic preparations having increased effectiveness, processes for their manufacture and method for increasing the antibiotic action of antibiotics
CIBA GEIGY CORP21 citations82
US4406889ASep 27, 1983
Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
CIBA GEIGY CORP22 citations82
US5637605AJun 10, 1997
α-fluoro-α-1-(1,2,4-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors
CIBA GEIGY CORP12 citations74
US5395855AMar 7, 1995
Hydrazones
CIBA GEIGY CORP10 citations74
US5376685ADec 27, 1994
Arylhydrazones using as SAMDC inhibitors
CIBA GEIGY CORP11 citations74
US5376669ADec 27, 1994
α-fluoro-α-(1,2,3-triazolyl)-phenylmethyl derivatives useful as aromatase inhibitors
CIBA GEIGY CORP8 citations74
US5227393AJul 13, 1993
α-fluoro-α-tetrazolyl-phenylmethyl derivatives useful as aromatase inhibitors
CIBA GEIGY CORP9 citations74
US4273766AJun 16, 1981
Nitroso-urea derivatives
CIBA GEIGY CORP7 citations74
US4397844AAug 9, 1983
Antigen derivatives and processes for their preparation
CIBA GEIGY CORP11 citations72
US5610195AMar 11, 1997
Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives
CIBA GEIGY CORP2 citations63
US5516806AMay 14, 1996
Ornithine decarboxylase inhibiting cyclic aminooxy compounds
CIBA GEIGY CORP5 citations63
US5457209AOct 10, 1995
4-[α(cyanophenyl)-1-(1,2,3-triazolyl)methyl]-benzonitrile
CIBA GEIGY CORP3 citations63
US5354761AOct 11, 1994
Bipyridyls
CIBA GEIGY CORP3 citations63
US5322852AJun 21, 1994
Aminooxy piperidines as ornithine decarboxylase inhibitors
CIBA GEIGY CORP2 citations63
US5238941AAug 24, 1993
Arylhydrazones and pharmaceutical compositions thereof
CIBA GEIGY CORP3 citations63
US5169867ADec 8, 1992
Hydroxylamine compounds
CIBA GEIGY CORP2 citations63
US4857660AAug 15, 1989
Certain 1-phenyl-cyclobutane-1,3-dicarboxylic acid type compounds
CIBA GEIGY CORP1 citations62
US4839379AJun 13, 1989
Substituted azabicycloalkanes, the use thereof, pharmaceutical compositions containing them
CIBA GEIGY CORP6 citations62
US4677129AJun 30, 1987
Substituted-3-azabicyclo[3.1.1]heptane-2,4-diones useful for treating hormone-dependent diseases
CIBA GEIGY CORP2 citations62
US4177344ADec 4, 1979
Anhydro-sugars
CIBA GEIGY CORP2 citations62
US4112075ASep 5, 1978
Furanose-O-pyridylcarboxylic acid esters
CIBA GEIGY CORP3 citations62
US4574058AMar 4, 1986
Antigen derivatives and processes for their preparation
CIBA GEIGY CORP6 citations61
US5639911AJun 17, 1997
Hydrazones
CIBA GEIGY CORP0 citations50
NOVARTIS AG
2 patentsUS5840911ANov 24, 1998
Imidazole derivatives, their preparation and their use as S-adenosylmethionine decarboxylase (=SAMDC) inhibitors
NOVARTIS AG16 citations74
US5834486ANov 10, 1998
Piperidinyl-2-alkyl, substituted linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation
NOVARTIS AG0 citations52